109 related articles for article (PubMed ID: 30421156)
21. Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy.
Rantaniemi L; Tammela TLJ; Kujala P; Murtola TJ
Scand J Urol; 2018 Aug; 52(4):269-276. PubMed ID: 30362865
[TBL] [Abstract][Full Text] [Related]
22. Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS study.
Rohrmann S; Garmo H; Malmström H; Hammar N; Jungner I; Walldius G; Van Hemelrijck M
Atherosclerosis; 2016 Aug; 251():85-93. PubMed ID: 27289190
[TBL] [Abstract][Full Text] [Related]
23. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
[TBL] [Abstract][Full Text] [Related]
24. Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
Seal US; Doe RP; Byar DP; Corle DK
Cancer; 1976 Sep; 38(3):1095-107. PubMed ID: 182347
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D, PTH, and calcium in relation to survival following prostate cancer.
Brändstedt J; Almquist M; Manjer J; Malm J
Cancer Causes Control; 2016 May; 27(5):669-77. PubMed ID: 27023469
[TBL] [Abstract][Full Text] [Related]
26. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging.
Hubbard JS; Rohrmann S; Landis PK; Metter EJ; Muller DC; Andres R; Carter HB; Platz EA
Urology; 2004 Feb; 63(2):253-8. PubMed ID: 14972466
[TBL] [Abstract][Full Text] [Related]
27. Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
Ghoshal A; Garmo H; Hammar N; Jungner I; Malmström H; Walldius G; Van Hemelrijck M
BMC Cancer; 2018 Nov; 18(1):1169. PubMed ID: 30477464
[TBL] [Abstract][Full Text] [Related]
28. Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists.
Bosco C; Wong C; Garmo H; Crawley D; Holmberg L; Hammar N; Adolfsson J; Stattin P; Van Hemelrijck M
BJU Int; 2018 Feb; 121(2):260-267. PubMed ID: 28940667
[TBL] [Abstract][Full Text] [Related]
29. Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort study.
Lundgren PO; Kjellman A; Norming U; Gustafsson O
Prostate; 2020 Jul; 80(10):777-781. PubMed ID: 32368817
[TBL] [Abstract][Full Text] [Related]
30. A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study.
Bos G; Dekker JM; Nijpels G; de Vegt F; Diamant M; Stehouwer CD; Bouter LM; Heine RJ;
Diabetologia; 2003 Jul; 46(7):910-6. PubMed ID: 12819906
[TBL] [Abstract][Full Text] [Related]
31. Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.
Allott EH; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):547-54. PubMed ID: 26809276
[TBL] [Abstract][Full Text] [Related]
32. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
[TBL] [Abstract][Full Text] [Related]
33. The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort.
Nderitu P; Bosco C; Garmo H; Holmberg L; Malmström H; Hammar N; Walldius G; Jungner I; Ross P; Van Hemelrijck M
Int J Cancer; 2017 Sep; 141(6):1148-1160. PubMed ID: 28577304
[TBL] [Abstract][Full Text] [Related]
34. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study.
Yiu A; Van Hemelrijck M; Garmo H; Holmberg L; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
Oncotarget; 2017 Jun; 8(26):42332-42342. PubMed ID: 28418841
[TBL] [Abstract][Full Text] [Related]
35. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study.
Van Hemelrijck M; Jassem W; Walldius G; Fentiman IS; Hammar N; Lambe M; Garmo H; Jungner I; Holmberg L
Eur J Cancer; 2011 Sep; 47(13):2033-41. PubMed ID: 21486691
[TBL] [Abstract][Full Text] [Related]
36. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
[TBL] [Abstract][Full Text] [Related]
37. Midlife metabolic factors and prostate cancer risk in later life.
Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
[TBL] [Abstract][Full Text] [Related]
38. [Risk of cardiovascular death in relation to blood lipid composition in male inhabitants of Tyumen: results of a 12-year prospective study].
Akimova EV; Gakova EI; Pushkarev GS; Smaznov VIu; Kaiumova MM; Gafarov VV; Kuznetsov VA
Ter Arkh; 2012; 84(9):41-6. PubMed ID: 23091852
[TBL] [Abstract][Full Text] [Related]
39. Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort.
Holme I; Tonstad S
Eur J Prev Cardiol; 2013 Feb; 20(1):168-75. PubMed ID: 22131130
[TBL] [Abstract][Full Text] [Related]
40. The Combination of Elevated Triglycerides and Abnormal Fasting Glucose Increases Risk of Cerebral Infarction in Patients With Mild to Moderate Hypercholesterolemia: A Post Hoc Analysis of the MEGA Study.
Nakagami T; Nishimura R; Sone H; Tajima N
J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):169-73. PubMed ID: 24906541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
